CRNX · Categories · Upgrades

CRNX - Analyst upgrades

Crinetics Pharmaceuticals Inc. (CRNX) analyst upgrades - real-time wire coverage filtered to Upgrades only.

Recent Upgrades for CRNX

• 232d
  Crinetics Pharmaceuticals upgraded by Goldman with a new price target

  Goldman upgraded Crinetics Pharmaceuticals from Neutral to Buy and set a new price target of $67.00
• 587d
  Crinetics Pharmaceuticals upgraded by Jefferies with a new price target

  Jefferies upgraded Crinetics Pharmaceuticals from Hold to Buy and set a new price target of $55.00
• 1901d
  Crinetics Pharmaceuticals upgraded by JP Morgan with a new price target

  JP Morgan upgraded Crinetics Pharmaceuticals from Neutral to Overweight and set a new price target of $28.00

Other CRNX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings